Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$200M |
| 2 |
Danaher
DHR
|
+$146M |
| 3 |
iShares 1-5 Year Investment Grade Corporate Bond ETF
IGSB
|
+$138M |
| 4 |
Procter & Gamble
PG
|
+$122M |
| 5 |
RDS.B
Royal Dutch Shell PLC ADS Class B
RDS.B
|
+$109M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$3.89B |
| 2 |
Microsoft
MSFT
|
+$380M |
| 3 |
Alibaba
BABA
|
+$352M |
| 4 |
Wells Fargo
WFC
|
+$245M |
| 5 |
American Electric Power
AEP
|
+$243M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 11.91% |
| 2 | Technology | 7.43% |
| 3 | Financials | 6.52% |
| 4 | Consumer Discretionary | 5.69% |
| 5 | Industrials | 4.98% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1201
Howard Hughes
HHH
$3.99B
| $5.78M | 0.01% |
120,021
+52,048
| +77% | +$5.22M |
|
1202
Hershey
HSY
$38.2B
| $5.78M | 0.01% |
+43,619
| New | +$6.43M |
|
|
JIH
1203
DELISTED
Juniper Industrial Holdings, Inc.
JIH
| $5.77M | 0.01% |
+600,000
| New | +$5.89M |
|
1204
Edwards Lifesciences
EW
$52.2B
| $5.77M | 0.01% |
91,722
-1,260,546
| -93% | -$90.9M |
|
1205
Gibraltar Industries
ROCK
$1.37B
| $5.76M | 0.01% |
134,277
-315,495
| -70% | -$15.8M |
|
|
AMED
1206
DELISTED
Amedisys
AMED
| $5.76M | 0.01% |
31,382
-18,238
| -37% | -$3.24M |
|
1207
Equitable Holdings
EQH
$13.4B
| $5.76M | 0.01% |
398,389
-287,498
| -42% | -$6.28M |
|
1208
Tradeweb Markets
TW
$22.9B
| $5.75M | 0.01% |
136,682
-1,060,677
| -89% | -$48.6M |
|
1209
BancFirst
BANF
$3.78B
| $5.74M | 0.01% |
172,114
+73,795
| +75% | +$3.84M |
|
1210
Coherus Oncology
CHRS
$210M
| $5.73M | 0.01% |
353,446
-290,997
| -45% | -$5.38M |
|
1211
PUT
Biogen
BIIB
$32.2B
| $5.73M | 0.01% |
18,100
+13,500
| +293% | +$4.1M |
|
|
MNDT
1212
DELISTED
Mandiant, Inc. Common Stock
MNDT
| $5.72M | 0.01% |
541,055
-1,203,860
| -69% | -$17.3M |
|
1213
TriNet
TNET
$3.19B
| $5.72M | 0.01% |
151,886
+55,484
| +58% | +$2.89M |
|
1214
State Street SPDR S&P Biotech ETF
XBI
$11.5B
| $5.72M | 0.01% |
73,844
-24,829
| -25% | -$2.2M |
|
1215
Eldorado Gold
EGO
$12.1B
| $5.71M | 0.01% |
924,789
-19,155
| -2% | -$144K |
|
1216
HealthEquity
HQY
$8.81B
| $5.7M | 0.01% |
112,716
-154,330
| -58% | -$10.2M |
|
|
GRMN
1217
Garmin
GRMN
$56.2B
| $5.69M | 0.01% |
75,948
-77,682
| -51% | -$7.03M |
|
1218
Comfort Systems
FIX
$56.7B
| $5.69M | 0.01% |
155,640
-202,906
| -57% | -$8.99M |
|
|
AGR
1219
DELISTED
Avangrid, Inc.
AGR
| $5.68M | 0.01% |
129,722
+117,996
| +1,006% | +$5.94M |
|
1220
CALL
iShares MSCI Mexico ETF
EWW
$1.79B
| $5.67M | 0.01% |
200,000
-350,000
| -64% | -$14.6M |
|
1221
10x Genomics
TXG
$8.31B
| $5.66M | 0.01% |
90,888
+65,802
| +262% | +$5.14M |
|
|
QTNT
1222
DELISTED
Quotient Limited Ordinary Shares
QTNT
| $5.66M | 0.01% |
35,840
-4,005
| -10% | -$1.05M |
|
1223
Pacira BioSciences
PCRX
$991M
| $5.65M | 0.01% |
168,454
-118,226
| -41% | -$4.91M |
|
1224
CALL
Penumbra
PEN
$12.8B
| $5.65M | 0.01% |
35,000
+7,100
| +25% | +$1.2M |
|
1225
TriMas Corp
TRS
$1.42B
| $5.64M | 0.01% |
244,226
+153,637
| +170% | +$4.22M |
|
Similar funds
Israel Englander's Q1 2020 Portfolio in Review
As of Q1 2020, Israel Englander held 4,928 positions worth $44.5B, down 44% from $79.9B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Israel Englander withdrew a net $21.4B in Q1 2020, closing 1,154 positions and reducing 1,745 holdings. Its most notable exit was Becton Dickinson, an estimated $152M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 12% of assets, up from 10% a quarter earlier, followed by Technology and Financials.
Against the trend, Israel Englander opened a new position in Danaher worth $133M.
- Israel Englander's largest Q1 2020 buy was Danaher: 1,082,448 shares worth $133M.
- Israel Englander added most to Allergan plc in Q1 2020, an estimated $200M increase.
- Israel Englander's biggest Q1 2020 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $3.89B.
- Israel Englander fully exited Becton Dickinson in Q1 2020, selling an estimated $152M.
- Israel Englander's ten largest holdings make up 18% of its $44.5B portfolio in Q1 2020.
- Israel Englander opened 789 new positions and closed 1,154 in Q1 2020.
- Israel Englander's portfolio value fell 44% quarter-over-quarter to $44.5B.
Based on Millennium Management's 13F filing for Q1 2020, filed 14 May 2020.